AI-based Software Providing Physicians with Quantitative Evaluation of CT Scans (QCT) for the Non-invasive Determination of Patient Eligibility for the Spiration Valve System Procedure to Treat Severe Emphysema CENTER VALLEY, […]
Accumen is helping healthcare get better, faster. Today, 3DR Labs, an Accumen Company, announced that it is now offering an artificial intelligence (AI) solution for diagnosing chronic lung disease through a new partnership with Imbio. 3DR Labs customers will have access to Imbio’s AI imaging technology effective immediately.
Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and treatment.
Imbio and Siemens Healthineers announced they are partnering to expand access to Imbio AI algorithms worldwide. Physicians will now be able to apply Imbio’s automated AI for quantitative image analysis directly through the Open Apps interface on Siemens’ syngo.via platform.
MINNEAPOLIS, Oct. 6, 2020 /PRNewswire/ — Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, has partnered with Genentech, a member of the Roche Group, to develop quantitative imaging […]
MINNEAPOLIS, March 27, 2020 /PRNewswire/ — Flywheel Exchange, a research data platform and Imbio, an AI-driven medical imaging company specializing in lung analysis, have teamed up to help global researchers accelerate understanding […]
We’re proud to announce that we have signed a partnership agreement with US-based artificial intelligence (AI) provider Imbio. Together we will provide a simple way for NHS organisations to use […]
Chicago, IL – November 27, 2017: Advanced Visualization solution provider, TeraRecon (WWW.TERARECON.COM) today announced a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes the most content-rich […]
NTT DATA Services, formerly Dell Services, today announced its partnership with Imbio, which will provide algorithms for lung analytics. The algorithms are designed to further enhance automated tools to assist […]
IMBIO AND GE HEALTHCARE TO SUPPORT MORE PERSONALIZED CT LUNG DIAGNOSIS WITH QUANTIFIABLE CLINICAL INSIGHTS MINNEAPOLIS, March 21, 2016 /PRNewswire/ — Imbio, a leader in fully automated, biomarker-based solutions for […]
